CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Open-market buy President & CEO bought 12,563 shares at $3.98 ($50,001)
- 4 Open-market buy CSO & COO bought 628 shares at $3.98 ($2,499)
- 4 Open-market buy Director bought 6,281 shares at $3.98 ($24,998)
- 4 Open-market buy General counsel and secretary bought 754 shares at $3.98 ($3,001)
- 4 Open-market buy Director bought 3,769 shares at $3.98 ($15,001)
- 4 Open-market buy Chief Financial Officer bought 754 shares at $3.98 ($3,001)
- 4 Open-market buy Director bought 8,794 shares at $3.98 ($35,000)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Delisting notice
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 4 Grant or award Director acquired 4,385 shares (grant or award)
- 4 Grant or award Director acquired 29,109 shares (grant or award)
- 4 Grant or award Director acquired 25,232 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 28,623 shares (grant or award)
- 4 Grant or award Director acquired 15,039 shares (grant or award)
- 8-K Event Executive or director change · Other events
Page 15 of 78 · 1,549 filings